Published in Am J Ophthalmol on November 24, 2009
Fyodorov-Zuev keratoprosthesis implantation: long-term results in patients with multiple failed corneal grafts. Graefes Arch Clin Exp Ophthalmol (2010) 0.91
Artificial corneas versus donor corneas for repeat corneal transplants. Cochrane Database Syst Rev (2014) 0.84
Implantation of Iakymenko keratoprosthesis in patients with severe ocular injury. Int J Ophthalmol (2012) 0.79
Keratoconus: tissue engineering and biomaterials. J Funct Biomater (2014) 0.79
High MMP-9 Expression May Contribute to Retroprosthetic Membrane Formation after KPro Implantation in Rabbit Corneal Alkali Burn Model. J Ophthalmol (2016) 0.75
Biocompatibility of poly(ethylene glycol) and poly(acrylic acid) interpenetrating network hydrogel by intrastromal implantation in rabbit cornea. J Biomed Mater Res A (2015) 0.75
Cost effectiveness of the type II Boston keratoprosthesis. Eye (Lond) (2010) 0.75
Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology (2006) 2.47
Evidence of molecular evolution driven by recombination events influencing tropism in a novel human adenovirus that causes epidemic keratoconjunctivitis. PLoS One (2009) 2.27
Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis (2013) 2.21
Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen. J Clin Microbiol (2009) 2.11
Computational analysis and identification of an emergent human adenovirus pathogen implicated in a respiratory fatality. Virology (2010) 1.82
Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet (2013) 1.79
Using the whole-genome sequence to characterize and name human adenoviruses. J Virol (2011) 1.65
Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin (2007) 1.61
Global corneal blindness and the Boston keratoprosthesis type I. Am J Ophthalmol (2010) 1.60
Acanthamoeba migration in an electric field. Invest Ophthalmol Vis Sci (2013) 1.42
Wide-angle fundus imaging through the Boston keratoprosthesis. Retina (2013) 1.40
A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol (2004) 1.39
Chemokine CXCL1/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis. J Interferon Cytokine Res (2009) 1.38
Inflammation and the nervous system: the connection in the cornea in patients with infectious keratitis. Invest Ophthalmol Vis Sci (2011) 1.37
Genetic analysis of a novel human adenovirus with a serologically unique hexon and a recombinant fiber gene. PLoS One (2011) 1.34
Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J Virol (2003) 1.33
Computational analysis of human adenovirus type 22 provides evidence for recombination among species D human adenoviruses in the penton base gene. J Virol (2009) 1.32
Molecular evolution of human adenoviruses. Sci Rep (2013) 1.29
Molecular evolution of human species D adenoviruses. Infect Genet Evol (2011) 1.25
Characterizing, typing, and naming human adenovirus type 55 in the era of whole genome data. J Clin Virol (2013) 1.18
Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol (2002) 1.17
Importance of nutrition to corneal grafts when used as a carrier of the Boston Keratoprosthesis. Cornea (2007) 1.14
Genomic and bioinformatics analysis of human adenovirus type 37: new insights into corneal tropism. BMC Genomics (2008) 1.14
Human adenovirus type 19: genomic and bioinformatics analysis of a keratoconjunctivitis isolate. Virus Res (2008) 1.13
Optical functional properties of the Boston Keratoprosthesis. Invest Ophthalmol Vis Sci (2009) 1.13
Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea (2009) 1.12
UBIAD1 mutation alters a mitochondrial prenyltransferase to cause Schnyder corneal dystrophy. PLoS One (2010) 1.12
Adenoviral keratoconjunctivitis in a tertiary care eye clinic. Cornea (2006) 1.11
Ocular surface squamous neoplasia: a standard of care survey. Cornea (2005) 1.10
Computational analysis of two species C human adenoviruses provides evidence of a novel virus. J Clin Microbiol (2011) 1.10
The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience. Cornea (2011) 1.09
Overreliance on the hexon gene, leading to misclassification of human adenoviruses. J Virol (2012) 1.09
A drug-eluting contact lens. Invest Ophthalmol Vis Sci (2009) 1.08
Fungal colonization and infection in Boston keratoprosthesis. Cornea (2007) 1.07
Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Ophthalmology (2008) 1.07
Alkali burn to the eye: protection using TNF-α inhibition. Cornea (2014) 1.07
Adenovirus type 37 keratitis in the C57BL/6J mouse. Invest Ophthalmol Vis Sci (2007) 1.07
The role of soft contact lenses as an adjunct to the Boston keratoprosthesis. Int Ophthalmol Clin (2008) 1.07
Predicting the next eye pathogen: analysis of a novel adenovirus. MBio (2013) 1.06
Corneal IL-8 expression following adenovirus infection is mediated by c-Src activation in human corneal fibroblasts. J Immunol (2003) 1.06
Expanding application of the Boston type I keratoprosthesis due to advances in design and improved post-operative therapeutic strategies. Semin Ophthalmol (2010) 1.06
Corneal cell survival in adenovirus type 19 infection requires phosphoinositide 3-kinase/Akt activation. J Virol (2005) 1.05
Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma. Dev Neurobiol (2007) 1.04
Evidence-based treatment of herpes simplex virus keratitis: a systematic review. Ocul Surf (2007) 1.04
Viral capsid is a pathogen-associated molecular pattern in adenovirus keratitis. PLoS Pathog (2010) 1.04
The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol (2008) 1.04
The Boston Keratoprosthesis in severe ocular trauma. Can J Ophthalmol (2008) 1.03
Analysis of human adenovirus type 19 associated with epidemic keratoconjunctivitis and its reclassification as adenovirus type 64. Invest Ophthalmol Vis Sci (2012) 1.03
Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. Am J Ophthalmol (2007) 1.03
Diagnostic and therapeutic considerations in fungal keratitis. Int Ophthalmol Clin (2011) 1.02
Retention of the Boston keratoprosthesis type 1: multicenter study results. Ophthalmology (2013) 1.00
The genetics of keratoconus. Semin Ophthalmol (2013) 1.00
Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results. Ophthalmology (2012) 0.98
Genomic characterization of human adenovirus 36, a putative obesity agent. Virus Res (2010) 0.96
Histopathology of Salzmann nodular corneal degeneration. Cornea (2008) 0.95
Modulation of corneal epithelial cell functions by the neutrophil-derived inflammatory mediator CAP37. Invest Ophthalmol Vis Sci (2004) 0.95
Glaucoma progression and role of glaucoma surgery in patients with Boston keratoprosthesis. Cornea (2014) 0.95
The Boston Keratoprosthesis: comparing corneal epithelial cell compatibility with titanium and PMMA. Cornea (2009) 0.95
Vitronectin: a possible determinant of adenovirus type 19 tropism for human corneal epithelium. Am J Ophthalmol (2005) 0.94
Repeat penetrating keratoplasty versus the Boston keratoprosthesis in graft failure. Int Ophthalmol Clin (2005) 0.94
Human adenovirus type 19 infection of corneal cells induces p38 MAPK-dependent interleukin-8 expression. Virol J (2008) 0.94
Corneal expression of the inflammatory mediator CAP37. Invest Ophthalmol Vis Sci (2002) 0.94
Characterization of retrokeratoprosthetic membranes in the Boston type 1 keratoprosthesis. Arch Ophthalmol (2011) 0.94
Anti-inflammatory effect of pigment epithelium-derived factor in DBA/2J mice. Mol Vis (2009) 0.93
Computational and serologic analysis of novel and known viruses in species human adenovirus D in which serology and genomics do not correlate. PLoS One (2012) 0.93
A novel implantable glaucoma valve using ferrofluid. PLoS One (2013) 0.93
Titanium back plate for a PMMA keratoprosthesis: clinical outcomes. Graefes Arch Clin Exp Ophthalmol (2011) 0.92
Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium. Ocul Surf (2005) 0.92
Glaucoma and keratoprosthesis surgery: role of adjunctive cyclophotocoagulation. J Glaucoma (2009) 0.91
JNK regulates MCP-1 expression in adenovirus type 19-infected human corneal fibroblasts. Invest Ophthalmol Vis Sci (2005) 0.90
Virulence factor profiles and antimicrobial susceptibilities of ocular bacillus isolates. Curr Eye Res (2006) 0.89
The TFOS International Workshop on Contact Lens Discomfort: executive summary. Invest Ophthalmol Vis Sci (2013) 0.89
Infectious endophthalmitis in Boston keratoprosthesis: incidence and prevention. Acta Ophthalmol (2014) 0.89
The revolution in viral genomics as exemplified by the bioinformatic analysis of human adenoviruses. Viruses (2010) 0.88
Ocular rosacea: an update on pathogenesis and therapy. Curr Opin Ophthalmol (2004) 0.88
The Boston keratoprosthesis in herpetic keratitis. Arch Ophthalmol (2007) 0.87
Contact lenses for drug delivery. Semin Ophthalmol (2009) 0.87
Computational analysis of four human adenovirus type 4 genomes reveals molecular evolution through two interspecies recombination events. Virology (2013) 0.87
Relapsing polychondritis: systemic and ocular manifestations, differential diagnosis, management, and prognosis. Semin Ophthalmol (2011) 0.87
A review of corneal melting after Boston Keratoprosthesis. Semin Ophthalmol (2014) 0.87
A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model. J Asthma Allergy (2013) 0.86
Activation of focal adhesion kinase in adenovirus-infected human corneal fibroblasts. Invest Ophthalmol Vis Sci (2002) 0.86
Boston keratoprosthesis treatment of herpes zoster neurotrophic keratopathy. Ophthalmology (2008) 0.86
Epibulbar nodular fasciitis associated with floppy eyelids. Cornea (2005) 0.86
In vitro and in vivo assessment of titanium surface modification for coloring the backplate of the Boston keratoprosthesis. Invest Ophthalmol Vis Sci (2013) 0.86
Corneal alkali burns: a review of the literature and proposed protocol for evaluation and treatment. Int Ophthalmol Clin (2013) 0.85
Relation of sensory peripheral neuropathy in Sjögren syndrome to anti-Ro/SSA. J Clin Rheumatol (2012) 0.85
Hydroxyapatite for keratoprosthesis biointegration. Invest Ophthalmol Vis Sci (2011) 0.85
Homologous recombination in E3 genes of human adenovirus species D. J Virol (2013) 0.85
Intraocular pressure measurement by radio wave telemetry. Invest Ophthalmol Vis Sci (2011) 0.85
The E3 CR1-gamma gene in human adenoviruses associated with epidemic keratoconjunctivitis. Virus Res (2011) 0.84